Kedrion Biopharma Advances Rare Disease Scientific Evidence Generation at ISTH 2026

New presentations and expert-led scientific discussions underscore Kedrion's commitment to improving diagnosis, supporting disease awareness, and scientific exchange in rare diseases FORT LEE, N.J., July 14, 2026 /PRNewswire/ -- Kedrion Biopharma, a biopharmaceutical company that produces...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.